Literature DB >> 35783361

Molecular Biology and Diversification of Human Retroviruses.

Morgan E Meissner1,2, Nathaniel Talledge1,3,4, Louis M Mansky1,3,2,4.   

Abstract

Studies of retroviruses have led to many extraordinary discoveries that have advanced our understanding of not only human diseases, but also molecular biology as a whole. The most recognizable human retrovirus, human immunodeficiency virus type 1 (HIV-1), is the causative agent of the global AIDS epidemic and has been extensively studied. Other human retroviruses, such as human immunodeficiency virus type 2 (HIV-2) and human T-cell leukemia virus type 1 (HTLV-1), have received less attention, and many of the assumptions about the replication and biology of these viruses are based on knowledge of HIV-1. Existing comparative studies on human retroviruses, however, have revealed that key differences between these viruses exist that affect evolution, diversification, and potentially pathogenicity. In this review, we examine current insights on disparities in the replication of pathogenic human retroviruses, with a particular focus on the determinants of structural and genetic diversity amongst HIVs and HTLV.

Entities:  

Keywords:  diversification; human T-cell leukemia virus; human immunodeficiency virus; molecular biology; retrovirus

Year:  2022        PMID: 35783361      PMCID: PMC9242851          DOI: 10.3389/fviro.2022.872599

Source DB:  PubMed          Journal:  Front Virol        ISSN: 2673-818X


  232 in total

1.  Virus mutators and antimutators: roles in evolution, pathogenesis and emergence.

Authors:  L M Mansky; K S Cunningham
Journal:  Trends Genet       Date:  2000-11       Impact factor: 11.639

2.  Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.

Authors:  Qin Yu; Renate König; Satish Pillai; Kristopher Chiles; Mary Kearney; Sarah Palmer; Douglas Richman; John M Coffin; Nathaniel R Landau
Journal:  Nat Struct Mol Biol       Date:  2004-04-18       Impact factor: 15.369

3.  Human Immunodeficiency Virus (HIV).

Authors: 
Journal:  Transfus Med Hemother       Date:  2016-05-09       Impact factor: 3.747

4.  Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004.

Authors:  Joris Hemelaar; Eleanor Gouws; Peter D Ghys; Saladin Osmanov
Journal:  AIDS       Date:  2006-10-24       Impact factor: 4.177

5.  Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat.

Authors:  Guocheng He; David M Margolis
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

6.  Human APOBEC3G-mediated editing can promote HIV-1 sequence diversification and accelerate adaptation to selective pressure.

Authors:  Eun-Young Kim; Tanmoy Bhattacharya; Kevin Kunstman; Peter Swantek; Fransje A Koning; Michael H Malim; Steven M Wolinsky
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

7.  HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation.

Authors:  Jonathan M O Rawson; Sean R Landman; Cavan S Reilly; Louis M Mansky
Journal:  Retrovirology       Date:  2015-07-10       Impact factor: 4.602

8.  Mechanistic and Kinetic Differences between Reverse Transcriptases of Vpx Coding and Non-coding Lentiviruses.

Authors:  Gina M Lenzi; Robert A Domaoal; Dong-Hyun Kim; Raymond F Schinazi; Baek Kim
Journal:  J Biol Chem       Date:  2015-10-19       Impact factor: 5.157

9.  Remodeling of the Core Leads HIV-1 Preintegration Complex into the Nucleus of Human Lymphocytes.

Authors:  Anastasia Gazi; Blandine Monel; Stella Frabetti; Viviana Scoca; Guillermo Blanco-Rodriguez; Florian Mueller; Olivier Schwartz; Jacomine Krijnse-Locker; Pierre Charneau; Francesca Di Nunzio
Journal:  J Virol       Date:  2020-05-18       Impact factor: 5.103

10.  Viral quasispecies.

Authors:  Esteban Domingo; Celia Perales
Journal:  PLoS Genet       Date:  2019-10-17       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.